A Paradigm Shift for Extended VTE Thromboprophylaxis in Hospitalized, Nonsurgical, Acutely Ill Patients (Non-CE Presentation/Networking Event)
Jeff Nemeth, BSP, Pharm.D., MPA, CACP
Director of Pharmacy
Engelwood Hospital and Medical Center
Tuesday, November 27, 2018
85 Church Street
New Brunswick, NJ 08901
1. Review the burden of VTE in nonsurgical, acutely ill patients
2. Provide an overview of the unmet need for in-hospital and extended VTE thromboprophylaxis
3. Review the APEX clinical trial data
4. Provide an overview of Bevyxxa® (betrixaban) indication, safety information, dosing and
appropriate patient types
This program is sponsored by Portola Pharmaceuticals.
In accordance with PhRMA Code on Interactions with Health Care Professionals, attendance at this educational program is limited to health care professionals. Attendance by guests or spouses is not appropriate and cannot be accommodated.
This is not an independent educational program, and no CME credits will be provided.